Top news
FDA Warns About Post-COVID Vax Guillain-Barré Syndrome
By Judy George
Johnson & Johnson Vaccine Is Linked To Neurological Disorder In Extremely Rare Cases
By Sharon Pruitt-Young
Health officials flag "small possible risk" of nervous system disorder in recipients of Johnson & Johnson's COVID-19 vaccine
By Alexander Tin
All coverage
J&J, AstraZeneca Explore Covid-19 Vaccine Modification in Response to Rare Blood Clots
By Parmy Olson & Jenny Strasburg
FDA to announce new warning on J&J Covid vaccine related to a rare autoimmune disorder, report says
By Berkeley Lovelace & Berkeley Lovelace Jr.
COVID-19 vaccine: Houston woman's sudden paralysis linked to Johnson & Johnson vaccine, she says
By Mycah Hatfield
FDA adds Guillain-Barre syndrome warning to J&J Covid shot
By Lauren Gardner & Erin Banco
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine (Published 2021)
By Sharon LaFraniere & Noah Mercer Weiland
FDA warns of potential rare neurological complication with Johnson & Johnson coronavirus vaccine
By Amanda Sealy, John Bonifield & Maggie Fox
FDA adds new warning on Johnson & Johnson vaccine related to rare autoimmune disorder
By Lena Sun & Laurie McGinley
J&J, AstraZeneca explore modifying Covid vaccines in response to rare blood clot issue
By Berkeley Lovelace & Berkeley Lovelace Jr.